While the global community strives to ensure program sustainability, the sad reality is that only a few of these interventions will continue after donor support and technical assistance ends. In addition, many of these projects will end with limited evidence that only includes the impact on health outcomes within a finite number of facilities and districts. As the global community begins to support progress towards universal health coverage (UHC) in low- and middle-income countries, we should ask ourselves: who’s going to pay when the donor support and technical assistance have gone?
These days, it’s rare to point to the U.S. health sector as a model for anything other than chaos and complexity, but there are both lessons learned from mistakes and occasional beacons of hope like the Ryan White HIV/AIDS Program that can be instructive for countries—especially low- and middle-income countries—seeking to stretch limited health funding to achieve universal health coverage.
We need to look at whether people have the right mix of incentives to avoid unhealthy lifestyle choices, and to access preventive health, such as vaccinating their children, using contraceptives for birth spacing or to avoid pregnancy, using condoms for disease prevention, and sleeping under bed nets in malarial zones. But just as importantly, we need to ensure that health care providers, both individual and institutional, have the right alignment of incentives to deliver high quality, affordable health services and pharmaceuticals.
Providing and maintaining continuous access to health products for the most difficult-to-reach populations necessitates the development of agile supply chains that rely on a multiplicity of partners and strategies to improve service delivery.
For World Immunization Week, JSI’s Craig Burgess offers recommendations on how we can work together to create immunization equity for all.
JSI’s Chris Wright looks ahead to the scenarios that will require new approaches to health supply chains in low and middle income countries.
In advance of the Ministerial Conference on Immunization in Afrcia, JSI President Joel Lamstein weighs in on the importance of vaccine supply chains in improving health equity and outcomes.
As countries strive to meet short- and long-term health goals, the need for medicines and medical devices required to reduce the global burden of common maternal and childhood illnesses has increased. But none of these goals can be realized without a dependable public health supply chain—the complicated system that gets medicines and supplies from where they are manufactured to the people who need them and are often a world away.
On December 12, 2015, a coalition of more than 600 global partners marked Universal Health Coverage Day, the three year anniversary of the unanimous adoption of a UN General Assembly resolution that counseled governments to provide universal health coverage (UHC) to their people. Greater numbers of countries are pursuing UHC reforms, and we want these reforms to result in reliable access to high quality reproductive health commodities for all women.
For Universal Health Coverage (UCH) Day, JSI’s Leslie Patykewich underscores the necessity of reproductive health commodity security to realizing UHC.